Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
The University of Utah provided all conflict of interest disclosures for government funded health research and human subject studies from 2012 to 2019. The university publicly discloses conflicts of interest for public health service funded research and human subjects studies that have a managed conflict of interest for an investigator on the study.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michael Deininger
University of Utah
Should you be removed from our database? Contact us at [email protected]. Read more below.
Incyte
Income for Consulting/Advisory Board
AbbVie M16-109»A Phase 2 Single-Arm, Open-Label Study Evaluating Tolerability and Efficacy of Navitoclax in Combination with Ruxolitinib in Subjects with Myelofibrosis Incorporating Amendments
Filed between 2012-2019.
Tell us what you know about Michael Deininger's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Michael Deininger”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Michael Deininger | University of Utah | Conflict of Interest | Bristol-Myers Squibb | $5,000-9,999 |
| Michael Deininger | University of Utah | Conflict of Interest | Pfizer | $5,000-9,999 |
| Michael Deininger | University of Utah | Conflict of Interest | Novartis | $10,000-19,999 |
| Michael Deininger | University of Utah | Conflict of Interest | Pfizer | $10,000-19,999 |
| Michael Deininger | University of Utah | Conflict of Interest | Pfizer | $5,000-9,999 |
| Michael Deininger | University of Utah | Conflict of Interest | Ariad | $5,000-9,999 |
| Michael Deininger | University of Utah | Conflict of Interest | Pfizer | $10,000-19,999 |
| Michael Deininger | University of Utah | Conflict of Interest | Pfizer | $10,000-19,999 |
| Michael Deininger | University of Utah | Conflict of Interest | Pfizer | $10,000-19,999 |
| Michael Deininger | Medical College of Wisconsin | Conflict of Interest | Pfizer | $10,000 - $19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.